June 4-8, 2021; Online at https://conferences.asco.org/am
Clinical benefit of sotorasib in patients with previously treated KRAS p.G12C–mutated NSCLC observed across subgroups prespecified by baseline characteristics and in exploratory analyses of molecularly defined subgroups.